Professional Medical Expertise Company (A Saudi Joint Stock Company) (Saudi Arabia)

The Company's activities consist of the Agents involved in the sale of medicines. Drug warehousing activities. Retail sale of medical equipment, tools and supplies.Medical Devices warehouse activities.Legal representation of medical products and devices' manufacturers
The Company was established under the name of Socrates Specialized Trading Company by Ms. Nouf Ahmed Abdullah Al-Bassam and Mr. Nasser Mubarak Abdullah Al-Qahtani as a Saudi limited liability company,with
a capital of one hundred thousand Saudi Riyals (SAR 100,000) divided into one hundred (100) fully paid shares with a nominal value of one thousand Saudi Riyals (SAR 1,000) per share, pursuant to the articles of
association registered with the notary public at the Ministry of Commerce on 1430-14-06H (corresponding to 07/06/2009G) and Commercial Registration No. 2051040259 dated 24/06/1430H (corresponding to
17/06/2010G) issued from Al Khobar.
On 05/08/1431H (corresponding to 17/07/2010G) the Company's registered office was moved to Dhahran, thus the Company was thereafter registered under Commercial Registration No. 2052001627 dated 14/08/1431H
(corresponding to 26/07/2010G) issued in Dhahran.
On 03/09/1433H (corresponding to 22/07/2012G), Mr. Nasser Mubarak Abdullah Al-Qahtani waived all of his five (5) shares in the Company to Mr. Abdulrahman Sameer Suleiman Al-Omran as a new shareholder in the
Company, and the Company's name changed from Socrates Specialized Trading Company to Professional Medical Expertise Company.
On 03/06/1434H (corresponding to 13/04/2013G), Mr. Abdulrahman Sameer Suleiman Al-Omran waived all of his five (5) shares in the Company to Mr. Mohammad Jamal Mohammad Al Mudayan as a new shareholder in the Company.
On 28/12/1435H (corresponding to 22/10/2014G), Ms. Nouf Ahmed Abdullah Al-Bassam waived all her shares in the Company, which amounted to ninety-five (95) shares, to Al-Omran Holding Company as a new
shareholder in the Company. Furthermore, Mr. Abdulrahman Sameer Suleiman Al-Omran waived all his shares in the Company, amounting to five (5) shares, to Elite Investments Company as a new Shareholder in the Company.
On 08/06/1441H (corresponding to 02/02/2020G), Al-Omran Holding Company waived its shares, amounting to thirty (30) shares in the Company, and Elite Investments Company waived all its shares in the Company, amounting to five (5) shares, to Care 2 Health Trading LLC (sole shareholding) as a new shareholder in the Company.
On 21/11/1441H (corresponding to 12/07/2020G), the Company's capital was increased from one hundred thousand Saudi Riyals (SAR 100,000) to one hundred and thirty thousand Saudi Riyals (SAR 130,000) divided into one hundred thirty (130) fully paid shares with a nominal value of one thousand Saudi Riyals (SAR 1,000) per share, through the issuance of new shares in favor of Care 2 Health Trading LLC and in favor of Mr.Riyadh Abdullah Rashid Abunayan as a new shareholder in the Company, in exchange for a cash contribution.
On 28/03/1443H (corresponding to 03/11/2021G), the Company's capital was increased from one hundred and thirty thousand Saudi Riyals (SAR 130,000) to five hundred thousand Saudi Riyals (SAR 500,000) divided into five hundred (500) fully paid shares with a nominal value of one thousand Saudi Riyals (SAR 1,000) per share by way of issuance of new shares in favor of every shareholder, in exchange for a cash contribution.
On 05/05/1443H (corresponding to 09/12/2021G), the shareholders approved the conversion of the Company from a limited liability company to a (closed) joint stock company (closed) and on 24/05/1443H(corresponding to 28/12/2021G), the Ministry of Commerce issued resolution No. 788 approving the announcement of the Company's conversion, and all procedures have been completed, including the amendment of the Commercial Register.
On 20/11/1443H (corresponding to 19/06/2022G), the Extraordinary General Assembly approved the Company's capital increase from five hundred thousand Saudi Riyals (SAR 500,000) to thirty-five million Saudi
Riyals (SAR 35,000,000) divided into three million five hundred thousand (3,500,000) ordinary shares paid in full through the transfer of twenty-seven million two hundred eighty-six thousand six hundred and thirteen
Saudi Riyals (SAR 27,286,613) from Related Parties through a credit relationship to the capital account and the transfer of seven million two hundred thirteen thousand three hundred and eighty-seven Saudi Riyals (SAR 7,213,387) from the retained earnings account to the capital account.
The Company's current capital is thirty-five million Saudi Riyals (SAR 35,000,000) divided into three million five hundred thousand (3,500,000) ordinary shares paid in full, with a nominal value of ten Saudi Riyals (SAR
10) per share
The Company's Mission :
is to provide distinctive solutions that improve quality of life and enable better patient care in the Kingdom and beyond. Based on its four core values of respect, sense of responsibility, continuous improvement and self-discipline, the Company envisions becoming the GCC's leading supplier of quality-enhancing medical solutions. The foundations on which the Company is built include:
- satisfying its customers as a key factor in achieving its objectives;
- patient care and well-being, as patients are the Company's eventual beneficiaries;
- the pursuit of perfection and excellence in all its endeavors;
- professionalism to exceed expectations;
- responsibility and its application in all exchanges;
- honesty and integrity, leading to customers placing their trust in the Company; and
- respect toward all of the Company's employees and contribution to their development, while rewarding them equitably
The Company's strategic priorities are to:
- put its customers first, by delivering outstanding personalized customer experiences and ensuring high quality outcomes and
value for money;
- maximize value through healthcare co-ordination, by being a trusted advisor to surgeons and hospitals and delivering efficient
seamless experiences that enable better patient care and treatment outcomes;
- be more than just a partner, by becoming a natural extension of customer's organizations, sourcing innovative medical technology
solutions to benefit its customers and to develop the skills of their operating room and intensive care unit staff;
- focus on people and the Company's continuous advancement, by developing and empowering people to make things easier,
faster, more personalized and responsive for its customers and partners; and
- participate in markets with the potential to make a significant impact, by expanding into activities business lines that meet the
most urgent healthcare needs of customers, and build on brand enhancement and the relationship with customers.